Elizabeth A Mullen
Children's Oncology Group · Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Elizabeth A Mullen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:53 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06401330 · A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Children's Oncology Group · recruiting · Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor, Stage III Mixed Cell Type Kidney Wilms Tumor · principal investigator
- N/ANCT01550393 · Biomarkers in Urine Samples From Patients With Wilms TumorChildren's Oncology Group · completed · Kidney Cancer · principal investigator
- N/ANCT01544569 · Studying Biomarkers in Samples From Young Patients With Rhabdoid TumorsChildren's Oncology Group · completed · Kidney Cancer · principal investigator
- N/ANCT00898365 · Study of Kidney Tumors in Younger PatientsChildren's Oncology Group · completed · Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma · principal investigator
- Ph3NCT00379340 · Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' TumorChildren's Oncology Group · completed · Stage III Kidney Wilms Tumor, Stage IV Kidney Wilms Tumor · principal investigator
- Ph3NCT00352534 · Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' TumorChildren's Oncology Group · completed · Stage I Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- COG NCTN Network Group Operations CenterU10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013
- Nemours NCI Community Oncology Research Program (NCORP)UG1CA189958 · NCI · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI Emi H Caywood · fiscal years 2014 to 2026Named on NCT00898365
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:53 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- 119 citationsRCR 4.9
- Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.J Clin Oncol · 201899 citationsRCR 4.5
- 78 citationsRCR 2.6
- Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.J Pediatr Surg · 201358 citationsRCR 2.5
- 57 citationsRCR 3.7
- Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.J Clin Oncol · 200741 citationsRCR 1.1
- Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.J Clin Oncol · 202236 citationsRCR 2.6
- 13 citationsRCR 2.5
- 11 citationsRCR 1.7
- Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study.Int J Cancer · 202410 citationsRCR 2.0